Amikacin Sulfate
Amikacin Sulfate
CONTRAINDICATION RESPONSIBILITIES
DURING:
Dx:
a. Monitor mood changes.
b. Monitor for adverse
effects
Tx:
a. Assist patient in taking
the medication.
b. Evaluate patient’s
hearing if he will be
receiving drug for no
longer than 2 weeks.
Notify prescriber if
patient has tinnitus,
vertigo, or hearing loss.
c. Watch for signs and
symptoms of super
infection (especially
URT), such as continued
fever, chills, and
increased pulse rate.
EDx:
a. Instruct patient to
verbalize feelings and
concerns.
AFTER:
Dx:
a. Assess knowledge/teach
patient appropriate
use ,interventions to
reduce side effects, and
adverse symptoms to
report.
b. Monitor for effectiveness
as exhibited by a
decrease in symptoms
c. Monitor for side effects.
Tx:
a. Provide safety measures
(e.g. adequate lighting,
raised side rails, etc.) to
prevent injuries.
b. Provide comfort
measures (e.g. voiding
before dosing, taking
food with drug, etc.) to
help patient tolerate drug
effects.
EDx:
a. Monitor patient
compliance to drug
therapy.
b. Monitor patient for 2-4
weeks to ascertain onset
of full therapeutic effect.
c. Instruct patient to
verbalize feelings and
concerns.